ESPN Offers Critical Take on 49ers' Trade for Brian Robinson Jr.

A crunchy twist on a classic, stacking chips inside a sandwich for extra flavor and texture. Would you try this combo?

Bristol Myers leans on new launches to offset legacy drug declines, while GSK's diverse portfolio and strong HIV lineup keep growth on track.

A federal judge tripled damages against the pharmacy benefits manager after finding it encouraged inflated Medicare drug ...

Ratings from both internal office staff and ICS umbrella employees saw the Lancaster firm come in the top 25, ahead of ...

Wes Streeting has walked away from talks with pharmaceutical giants on NHS drug costs amid a stand-off over rebates. The ...

Dynavax Technologies has revealed promising topline outcomes from the initial part of its Phase I/II clinical trial, ...

Mukherjee brings over 18 years of experience in digital strategy, e-commerce, and brand management, including leadership ...

GLP-1 drugs for diabetes and weight loss may influence patients’ cancer risk, usually lowering it but sometimes possibly ...

The Emeryville, California-based biotech has just released topline results from a phase 1/2 head-to-head study comparing its ...